Aquaculture and veterinary

The high costs associated with the prospection of bioactive compounds that is regularly done in the aquaculture industry, as well those from preclinical trials from the veterinary and pharmaceutical industries, make necessary the creation and implementation of biotechnological tools to reduce the associated economic risks. This is how the zebrafish has become the new “lab mice” for the food and pharmaceutical industries. On the other hand, the versatility of the zebra fish model allows us to evaluate the possible unwanted effects of compounds present in the environment (affluent and effluents of water in aquaculture) as well as those that were intentionally added (antibiotics, additives, etc.)


  • Functional diets
  • Evaluation of hatching, growth rate and reproduction under different treatments.
  • Immuno-stimulants and anti-inflammatory compounds.
  • Search for antioxidants.
  • Search for cell regeneration stimulants.
  • Search for potential anti-carcinogenic and anti-metastasis (Cellular migration and angiogenesis inhibitors)
  • Estimation of defects in embryonic development (embryonic toxicity, teratogenesis, citotoxicity and neurotoxicity).